tiprankstipranks
Advertisement
Advertisement
Niagen Bioscience: Tru Niagen‑Driven Beat, Durable Double‑Digit Growth Outlook, and FDA Litigation Upside Support Buy Rating
PremiumRatingsNiagen Bioscience: Tru Niagen‑Driven Beat, Durable Double‑Digit Growth Outlook, and FDA Litigation Upside Support Buy Rating
29d ago
Niagen Bioscience Reports Strong 2025 Results, Strategic Shift
Premium
Company Announcements
Niagen Bioscience Reports Strong 2025 Results, Strategic Shift
30d ago
Niagen Bioscience sees FY26 revenue up 10%-15%, implying $142.3M-$148.8M
Premium
The Fly
Niagen Bioscience sees FY26 revenue up 10%-15%, implying $142.3M-$148.8M
30d ago
Niagen Bioscience Divests Non-Core Analytical Standards Business
PremiumCompany AnnouncementsNiagen Bioscience Divests Non-Core Analytical Standards Business
1M ago
Niagen Bioscience secures new patent for nicotinamide riboside
Premium
The Fly
Niagen Bioscience secures new patent for nicotinamide riboside
1M ago
Niagen Bioscience partners with Truemed for pre-tax health payments
Premium
The Fly
Niagen Bioscience partners with Truemed for pre-tax health payments
3M ago
Niagen Bioscience announces results of Niagen supplementation in long COVID
PremiumThe FlyNiagen Bioscience announces results of Niagen supplementation in long COVID
5M ago
Niagen Bioscience announces $10M share repurchase program
Premium
The Fly
Niagen Bioscience announces $10M share repurchase program
5M ago
Niagen Bioscience Announces $10 Million Share Buyback
Premium
Company Announcements
Niagen Bioscience Announces $10 Million Share Buyback
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100